THE ABSORB BIORESORBABLE VASCULAR SCAFFOLDS ARE ASSOCIATED WITH LOW WALL SHEAR STRESS COMPARED TO XIENCE V: A BIOMECHANICAL ANALYSIS OF THE ABSORB III IMAGING STUDY

The Absorb bioresorbable vascular scaffold (BVS) has higher target lesion failure (TLF) rates at 3 years. Low wall shear stress (WSS) promotes several mechanisms related to device TLF. We hypothesized that, due to its larger strut size, BVS is more likely to be associated with Low WSS than Xience V